Neuropeptides
Volume 43, Issue 5 , Pages 371-385, October 2009

Effects of TRH and its analogues on primary cortical neuronal cell damage induced by various excitotoxic, necrotic and apoptotic agents

  • D. Jantas

      Affiliations

    • Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12 Street, PL 31-343 Krakow, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 12 6623368; fax: +48 12 6374500.
  • ,
  • L. Jaworska-Feil

      Affiliations

    • Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12 Street, PL 31-343 Krakow, Poland
  • ,
  • A.W. Lipkowski

      Affiliations

    • Center of Experimental and Clinical Medicine, Polish Academy of Sciences, Pawinskiego 5, PL 02-106 Warsaw, Poland
  • ,
  • W. Lason

      Affiliations

    • Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12 Street, PL 31-343 Krakow, Poland

Received 17 March 2009; accepted 18 July 2009. published online 10 August 2009.

Abstract 

The tripeptide thyrotropin-releasing hormone (TRH, pGlu-His-Pro-NH2) has been shown to possess neuroprotective activity in in vitro and in vivo models. Since its potential utility is limited by relatively rapid metabolism, metabolically stabilized analogues have been constructed. In the present study we investigated the influence of TRH and its three stable analogues: Montirelin (MON, CG-3703), RGH-2202 (L-6-keto-piperidine-2carbonyl-l-leucyl-l-prolinamide) and Z-TRH (N-carbobenzyloxy-pGlutamyl-Histydyl-Proline) in various models of mouse cortical neuronal cell injury. Twenty four hour pre-treatment with TRH and its analogues in low micromolar concentrations attenuated the neuronal cell death evoked by excitatory amino acids (EAAs: glutamate, NMDA, kainate, quisqualate) and hydrogen peroxide. All the peptides showed neuroprotective action on staurosporine (St)-evoked apoptotic neuronal cell death, but this effect was caspase-3 independent. Interestingly, in mixed neuronal-glial cell preparations only MON decreased St- and glutamate-evoked neurotoxicity. None of the peptides inhibited the doxorubicin- and lactacystin-induced neuronal cortical cell death, agents acting via activation of death receptor (FAS) or inhibition of proteasome function, respectively. Furthermore, we found that neither inhibitors of PI3-K (wortmannin, LY 294002) nor MAPK/ERK1/2 (PD 098059, U 0126) were able to inhibit neuroprotective properties of TRH and MON in St model of apoptosis. The protection mediated by TRH and MON it that model was also not connected with influence of peptides on the pro-apoptotic GSK-3β and JNK protein kinase expression and activity. Further studies showed that calpains, calcium-activated proteases were induced by Glu, but not by St in cortical neurons. Moreover, the Glu-evoked increase in spectrin alpha II cleavage product induced by calpains was blocked by TRH. The obtained data showed that the potency of TRH and its analogues in inhibiting EAAs- and H2O2-induced neuronal cell death from the highest to lowest activity was: MON>TRH>Z-TRH>RHG. Interestingly, all peptides were active against St-induced apoptosis, however, on concentration basis MON was far more potent than the other peptides. None of the peptides inhibited Dox- and LC-evoked apoptotic cell death. Additionally, the data exclude potential role of pro-survival (PI3-K/Akt and MAPK/ERK1/2) and pro-apoptotic (GSK-3β and JNK) pathways in neuroprotective effects of TRH and its analogues on St-induced neuronal apoptosis. Moreover, the results point to involvement of the inhibition of calpains in the TRH neuroprotective effect in Glu model of neuronal cell death.

Abbreviations: Akt, serine/threonine protein kinase Akt, PKB, protein kinase B, AMPA, alpha-amino-3-hydroxy-5-methylisoxazole propionate, DIV, days in vitro, Dox, doxorubicin, adriamycin, ERK1/2, extracellularly regulated protein kinase 1/2, Glu, glutamate, GSK-3, β glycogen synthase kinase-3β, JNK, c-Jun NH(2)-terminal kinase, KA, kainate, LC, lactacystin, LDH, lactate dehydrogenase, MON, CG-3703, Montirelin, 6-Me-5-oxothiomorpholinyl-3-carbonyl-His-Pro-NH2, NMDA, N-methyl-d-aspartate, QA, quisqualate, PI3-K, phosphatidylinositol-3 kinase, RGH, RGH-2202, posatirelin L-6-keto-piperidine-2-carbonyl-l-leucyl-l-prolinamide, St, staurosporine, TRH, pGlu-His-Pro-NH2, Z-TRH, AWL-4102, N-(carbobenzyloxy)-pGlutamyl-Histydyl-Proline

Keywords: Montirelin, RGH-2202, Z-pGlutamyl-Histydyl-Proline, Glutamate, NMDA, Kainate, AMPA, Quisqualate, Staurosporine, Doxorubicin, Lactacystin, Calpain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0143-4179(09)00082-1

doi:10.1016/j.npep.2009.07.002

Neuropeptides
Volume 43, Issue 5 , Pages 371-385, October 2009